UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Helminths in the gastrointestinal tract as modulators of immunity and pathology

American journal of physiology: Gastrointestinal and liver physiology, 2017-06, Vol.312 (6), p.G537-G549

2017

Link zum Volltext

Verfügbarkeit prüfen

Concerted IL-25R and IL-4Rα signaling drive innate type 2 effector immunity for optimal helminth expulsion

eLife, 2018-09, Vol.7

2018

Link zum Volltext

Verfügbarkeit prüfen

An increased risk of urinary tract infection precedes development of primary biliary cirrhosis

BMC gastroenterology, 2011-08, Vol.11 (1), p.95-95, Article 95

2011

Link zum Volltext

Verfügbarkeit prüfen

Macrophage Migration Inhibitory Factor (MIF) Is Essential for Type 2 Effector Cell Immunity to an Intestinal Helminth Parasite

Frontiers in immunology, 2019-10, Vol.10, p.2375-2375

2019

Link zum Volltext

Verfügbarkeit prüfen

Can Magnetic Resonance Enterography (MRE) replace ileo-colonoscopy for evaluating disease activity in Crohn's disease?

Baillière's best practice & research. Clinical gastroenterology, 2019-02, Vol.38-39, p.101621-101621, Article 101621

2019

Link zum Volltext

Verfügbarkeit prüfen

Primary biliary cirrhosis does not increase the risk of UTIs following diagnosis compared to other chronic liver diseases?

Liver international, 2013-03, Vol.33 (3), p.384-388

2013

Link zum Volltext

Verfügbarkeit prüfen

Improving 30-day mortality after PEG tube placement in England from 2007 to 2019: a retrospective national cohort analysis of 87,862 patients

Gastrointestinal endoscopy, 2022-12, Vol.96 (6), p.943-953.e11

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure

European heart journal, 2008-06, Vol.29 (11), p.1377-1385

2008

Link zum Volltext

Verfügbarkeit prüfen

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

European heart journal, 2008-06, Vol.29 (11), p.1377-1385

2008

Link zum Volltext

Verfügbarkeit prüfen

Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data

Drug design, development and therapy, 2019-12, Vol.13, p.4091-4105

2019

Link zum Volltext

Verfügbarkeit prüfen

The IL-25-dependent tuft cell circuit driven by intestinal helminths requires macrophage migration inhibitory factor (MIF)

Mucosal immunology, 2022-06, Vol.15 (6), p.1243-1256

2022

Link zum Volltext

Verfügbarkeit prüfen

Modulation of innate cells by helminth infection and helminth derived products

Varyani, Fumi

2019

Link zum Volltext
ProQuest

Concerted IL-25R and IL-4R[alpha] signaling drive innate type 2 effector immunity for optimal helminth expulsion

eLife, 2018-09, Vol.7

2018

Link zum Volltext

Verfügbarkeit prüfen

Primary biliary cirrhosis does not increase the risk of UTI s following diagnosis compared to other chronic liver diseases?

Liver international, 2013-03, Vol.33 (3), p.384-388

2013

Link zum Volltext

Verfügbarkeit prüfen

The communication of a secondary care diagnosis of autoimmune hepatitis to primary care practitioners: a population-based study

BMC health services research, 2013-05, Vol.13 (1), p.161-161, Article 161

2013

Link zum Volltext

Verfügbarkeit prüfen

Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland

Circulation. Heart failure, 2008-11, Vol.1 (4), p.234-241

2008

Link zum Volltext

Verfügbarkeit prüfen

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure : An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Commentary

European heart journal, 2008, Vol.29 (11)

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(16)
Dissertationen
(1)

Sprache

Englisch
(17)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Helminths in the gastrointestinal tract as modulators of immunity and pathology

Concerted IL-25R and IL-4Rα signaling drive innate type 2 effector immunity for optimal helminth expulsion

An increased risk of urinary tract infection precedes development of primary biliary cirrhosis

Macrophage Migration Inhibitory Factor (MIF) Is Essential for Type 2 Effector Cell Immunity to an Intestinal Helminth Parasite

Can Magnetic Resonance Enterography (MRE) replace ileo-colonoscopy for evaluating disease activity in Crohn's disease?

Primary biliary cirrhosis does not increase the risk of UTIs following diagnosis compared to other chronic liver diseases?

Improving 30-day mortality after PEG tube placement in England from 2007 to 2019: a retrospective national cohort analysis of 87,862 patients

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data

The IL-25-dependent tuft cell circuit driven by intestinal helminths requires macrophage migration inhibitory factor (MIF)

Modulation of innate cells by helminth infection and helminth derived products

Concerted IL-25R and IL-4R[alpha] signaling drive innate type 2 effector immunity for optimal helminth expulsion

Primary biliary cirrhosis does not increase the risk of UTI s following diagnosis compared to other chronic liver diseases?

The communication of a secondary care diagnosis of autoimmune hepatitis to primary care practitioners: a population-based study

Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure : An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Commentary

Suchergebnisse filtern